The Hamilton Depression Rating Scale (HDRS-17) remains a foundational instrument in psychiatric practice and clinical trials for quantifying the severity of…
Questions
17
Duration
20 min
Original title
HDRS-17 — Hamilton Depression Rating Scale
Adaptation
Hamilton Depression Rating Scale (HDRS-17)
Authors
Hamilton, M.
Created
1960
The Hamilton Depression Rating Scale (HDRS-17) remains a foundational instrument in psychiatric practice and clinical trials for quantifying the severity of depressive illness. Originally developed by Max Hamilton in 1960, this clinician-rated measure captures both the psychological and somatic manifestations of depression, offering a comprehensive snapshot of a patient's clinical state over the past week. By structuring the assessment of neurovegetative shifts, mood alterations, and psychomotor changes, it ensures consistency in symptom tracking across different treatment settings.
Unlike self-report measures that rely on subjective patient insight, the HDRS-17 leverages the clinician's objective observation and structured interviewing skills. It is highly sensitive to treatment-induced change, making it an excellent standard for evaluating the efficacy of pharmacotherapy or psychotherapeutic interventions. By anchoring depression symptoms to concrete behavioral and somatic markers, it provides a reliable, repeatable metric to guide clinical decision-making.
Example result
Fictitious result, computed from a sample set of answers.
Overall score
24/ 52
Reference clinician-administered rating scale, administered by a clinician during a semi-structured interview, designed to quantify the severity of depressive symptoms in an adult with an already identified depressive disorder. It is used to evaluate the initial severity of the episode, monitor its course over time, and assess treatment response (particularly to antidepressants). Scoring covers the past 7 days and relies on clinical observation and the practitioner's judgment.
0–7
Absence of depression
8–16
Mild depression
17–23
Moderate depression
24–52
Severe depression
24
Maximized the sum of sensitivity and specificity for the comparison of moderate vs. severe depression.
Scoring
Sum of the 17 items, total score from 0 to 52, item scoring varies depending on the item (see each question).
Have your patient take this test
Assign it in one click: your patient answers on their phone, you receive the score and its interpretation.
The HDRS-17 evaluates the overall severity of a major depressive episode by capturing both psychological distress and somatic neurovegetative signs.
Affective symptoms: Persistent low mood, feelings of hopelessness, and observable signs of emotional distress.
Cognitive features: Excessive guilt, automatic thoughts of worthlessness, suicidal ideation, and lack of clinical insight.
Neurovegetative shifts: Early, middle, and late insomnia, as well as distinct changes in appetite, weight, and libido.
Psychomotor changes: Observable retardation in speech and thought, or conversely, physical agitation and physical tension.
Somatic anxiety: Gastrointestinal, cardiovascular, and respiratory manifestations of anxiety, along with heightened hypochondriasis.
This scale is primarily designed for adults already experiencing a major depressive episode, particularly in inpatient or specialized outpatient settings where somatic symptoms are prominent.
When and why to use it
Clinicians rely on the HDRS-17 to transform qualitative clinical impressions into a structured, trackable severity metric.
Establishing baseline severity: Quantifies the initial depth of the depressive episode to inform treatment planning and case formulation.
Monitoring treatment response: Tracks symptom changes over time, particularly the neurovegetative and psychomotor shifts that often precede subjective mood improvements.
Guiding behavioral interventions: Highlights specific deficits in work, interests, and energy to help establish targeted behavioral activation goals.
Differentiating symptom profiles: Separates true melancholic features from alternative presentations, such as identifying a bipolar disorder prodrome when mood lability is high but physical retardation is low.
Anchoring subjective distress to a validated clinical score allows professionals to objectify remission criteria and adjust coping strategies or biological treatments effectively.
Clinical library
750+ clinical tools
A library built with and for clinicians, ready to use in session and extend between appointments.
Rate each item based on the patient's clinical state during the past 7 days, using information gathered from the clinical interview and clinical observation. Choose the level that best describes the observed symptomatology.
1. Depressed mood (sadness, hopelessness, helplessness, feelings of worthlessness)
Evaluates the pervasive nature of the patient's low mood and whether it is communicated spontaneously or only upon targeted questioning.
Absent
These feelings are reported only when asked
These feelings are spontaneously reported verbally
Communicates these feelings non-verbally (facial expression, posture, voice, tendency to cry)
Expresses these feelings almost exclusively, both verbally and non-verbally
2. Feelings of guilt
Assesses the presence and intensity of self-reproach, rumination over past errors, and delusional guilt.
Absent
Self-reproach, feels they have let people down
Ideas of guilt or ruminates over past errors or sinful deeds
Present illness is a punishment; delusional ideas of guilt
Hears accusatory or denunciatory voices and/or experiences threatening visual hallucinations
3. Suicide
Probes the spectrum of suicidality, ranging from passive death wishes to active ideation and recent suicide attempts.
Absent
Feels life is not worth living
Wishes they were dead or has any thoughts of possible death
Suicidal ideas or gestures
Attempts at suicide (any serious attempt)
4. Insomnia: early night
Captures difficulties with sleep onset and the latency period before falling asleep.
No difficulty falling asleep
Complains of occasional difficulty falling asleep (more than 30 minutes)
Complains of difficulty falling asleep every night
5. Insomnia: middle night
Measures sleep continuity and the frequency of nocturnal awakenings.
No difficulty
Patient complains of being restless and disturbed during the night
Waking during the night (any getting out of bed, except for urination)
6. Insomnia: early morning
Identifies terminal insomnia, where the patient wakes prematurely and cannot return to sleep.
No difficulty
Waking in the early hours of the morning but goes back to sleep
Unable to fall asleep again if they get out of bed
7. Work and activities
Evaluates the impact of depressive symptoms on the patient's daily functioning, occupational capacity, and engagement in hobbies.
No difficulty
Thoughts and feelings of incapacity, fatigue or weakness related to activities, work or hobbies
Loss of interest in activities, hobbies, or work, reported directly by the patient or indirectly through apathy, indecision, and hesitation
Decrease in time spent on activities or decreased productivity
Has stopped working because of present illness
8. Retardation (slowness of thought and speech, impaired ability to concentrate, decreased motor activity)
Observes the objective slowing of psychomotor functions, speech latency, and cognitive processing during the interview.
Normal speech and thought
Slight retardation at interview
Obvious retardation at interview
Interview difficult
Complete stupor
9. Agitation
Detects physical restlessness, inability to sit still, and overt expressions of motor tension.